In contrast to above-mentioned observations, one recently published study on oral squamous cell carcinoma has shown that dehydrocrenatidine mediates pro-apoptotic effects by inducing ERK1/2 and JNK1/2 phosphorylation. This evidence concerns the gene MAPK3 and oral cavity squamous cell carcinoma.